Larvol Delta - AIVITA-Biomedical-provides-update-of-ongoing-phase-2-glioblastoma-trial-from-yearend-survival-analysis

AV-GBM-1 - AiVita Biomedical

https://www.businesswire.com/news/home/20200408005162/en/AIVITA-Biomedical-Update-Ongoing-Phase-2-Glioblastoma

Apr 8, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next